JT
NERV icon

Jupiter Topco’s Minerva Neurosciences NERV Stock Holding History

Jupiter Topco’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.3M Buy
+4,386,027
New +$23.8M 0.01% 608

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Jupiter Topco's NERV Position: Q2 2026 in Review

Jupiter Topco opened a new position in Minerva Neurosciences (NERV) in Q2 2026: 4,386,027 shares worth $24.3M. The stake represents 0.01% of the portfolio and ranks #608 among its holdings.

55 funds tracked by Wall St. Rank hold NERV as of Q2 2026.

  • Jupiter Topco held 4,386,027 shares of Minerva Neurosciences worth $24.3M as of Q2 2026.
  • Minerva Neurosciences was a new Jupiter Topco position in Q2 2026.
  • Minerva Neurosciences made up 0.01% of Jupiter Topco's portfolio in Q2 2026, its #608 holding.
  • 55 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.